History | Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal) | Guidance | NICE

History

Invitation to participate

Final scope (PDF 261 KB)

Published:

05 October 2020
Final stakeholder list (PDF 188 KB)

Published:

05 October 2020
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 277 KB)

Published:

05 October 2020
Equality impact assessment (Scoping) (PDF 138 KB)

Published:

05 October 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 249 KB)

Published:

23 April 2020
Draft matrix post referral (PDF 187 KB)

Published:

23 April 2020